Inventor · disambiguated record
Fernando Padilla
Also filed as: PADILLA FERNANDO
14 granted patents·8 pending applications·27 citations·filing 2002–2022
87Inventor score
Files withHOFFMANN LA ROCHE6BLACK DIAMOND THERAPEUTICS INC4HERMANN JOHANNES CORNELIUS2LYCERA CORP2ROCHE PALO ALTO LLC2
Top patents by PatentIndex Score
22 records- 0183US6900220B2Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonistsSYNTEX LLC·Filed 2002·Granted May 31, 2005·14 cites·35 claims
- 0278US8901124B2Pyridazine amide compounds useful as SYK inhibitorsHOFFMANN LA ROCHE·Filed 2013·Granted Dec 2, 2014·4 cites·13 claims
- 0376US9334278B2Pyrrolo[2,3-B]pyrazines as SYK inhibitorsHOFFMANN LA ROCHE·Filed 2013·Granted May 10, 2016·3 cites·16 claims
- 0471US8658646B2Pyrrolopyrazine kinase inhibitorsCHEN SHAOQING·Filed 2012·Granted Feb 25, 2014·3 cites·17 claims
- 0569US10112935B2Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of diseaseLYCERA CORP·Filed 2016·Granted Oct 30, 2018·1 cites·32 claims
- 0661US7244738B2Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonistsROCHE PALO ALTO LLC·Filed 2004·Granted Jul 17, 2007·1 cites·11 claims
- 0759US7091200B2Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonistsSYNTEX LLC·Filed 2004·Granted Aug 15, 2006·1 cites·24 claims
- 0856US12435046B2Alkynyl quinazoline compoundsBLACK DIAMOND THERAPEUTICS INC·Filed 2020·Granted Oct 7, 2025·0 cites·20 claims
- 0954US2024368181A1Quinoxaline derivatives and uses thereofBLACK DIAMOND THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1052US2007265446A1Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonistsCONNOLLY TERRENCE J·Filed 2007·Application pending·0 cites
- 1151US10556898B2Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of diseaseLYCERA CORP·Filed 2019·Granted Feb 11, 2020·0 cites·31 claims
- 1250US2025017914A16-aza-quinoline derivatives and related usesBLACK DIAMOND THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1350US2024317752A16-substituted-9h-purine derivatives and related usesBLACK DIAMOND THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1447US2022388964A1(aza)indazolyl-aryl sulfonamide and related compounds and their use in treating medical conditionsHIBERCELL INC·Filed 2020·Application pending·0 cites
- 1545US2005124607A15-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonistsFiled 2004·Application pending·0 cites
- 1644US2007191406A1Heterocyclic antiviral compoundsROCHE PALO ALTO LLC·Filed 2007·Application pending·0 cites
- 1741US9988378B21 H-pyrazole and 4,5-disubstituted thiazole inhibitors of SYKHOFFMANN LA ROCHE·Filed 2013·Granted Jun 5, 2018·0 cites·1 claims
- 1841US9169259B2Imidazopyridazine compoundsHOFFMANN LA ROCHE·Filed 2012·Granted Oct 27, 2015·0 cites·21 claims
- 1940US10112928B2Inhibitors of SYKHOFFMANN LA ROCHE·Filed 2013·Granted Oct 30, 2018·0 cites·11 claims
- 2039US9701691B2Thienopyrimidine compoundsHOFFMANN LA ROCHE·Filed 2013·Granted Jul 11, 2017·0 cites·6 claims
- 2131US8921383B2Thiazolopyrimidine compoundsHERMANN JOHANNES CORNELIUS·Filed 2012·Granted Dec 30, 2014·0 cites·15 claims
- 2231US2012309746A1Triazolopyridine compoundsHERMANN JOHANNES CORNELIUS·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fernando Padilla files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →